AAAAAA
Results:
1-16
|
Results: 16
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., APOPTOSIS AND RESISTANCE TO DAUNORUBICIN IN HUMAN LEUKEMIC-CELLS, Leukemia, 11(7), 1997, pp. 1180-1186
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., ANTI-FAS APO-1 MONOCLONAL-ANTIBODY CH-11 DEPLETES GLUTATHIONE AND KILLS MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELLS/, Blood cells, molecules, & diseases, 22(1), 1996, pp. 2-9
Authors:
EFFERTH T
RUCKER G
FALKENBERG M
MANNS D
OLBRICH A
FABRY U
OSIEKA R
Citation: T. Efferth et al., DETECTION OF APOPTOSIS IN KG-1A LEUKEMIC-CELLS TREATED WITH INVESTIGATIONAL DRUGS, Arzneimittel-Forschung, 46(2), 1996, pp. 196-200
Authors:
VOLM M
EFFERTH T
GRABNER P
POMMERENKE EW
Citation: M. Volm et al., INDUCTION OF P-GLYCOPROTEIN, GLUTATHIONE-S-TRANSFERASE-PI, CATALASE, C-FOS AND C-ERBB1 IN RODENT CELL-LINES AFTER EXPOSURE TO DOXORUBICIN, ETHANOL AND CAFFEINE, International journal of oncology, 6(1), 1995, pp. 87-92
Authors:
EFFERTH T
FABRY U
GLATTE P
OSIEKA R
Citation: T. Efferth et al., INCREASED INDUCTION OF APOPTOSIS IN MONONUCLEAR-CELLS OF A GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT PATIENT, Journal of molecular medicine, 73(1), 1995, pp. 47-49
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., IS THERE A REALISTIC CHANCE FOR THE CLINICAL MODULATION OF MULTIDRUG-RESISTANCE, Onkologie, 18(3), 1995, pp. 258-260
Authors:
BUSSING A
KLOTZ M
SUZART K
EFFERTH T
GERLACH D
SCHNITZLER N
OSIEKA R
SCHWEIZER K
KAUFHOLD A
Citation: A. Bussing et al., SISTER-CHROMATID EXCHANGE INDUCING DNA LESIONS AND DEPRESSION OF ACTIVATION MARKERS ON THE SURFACE OF CULTURED PERIPHERAL-BLOOD MONONUCLEAR-CELLS AFTER THE ADDITION OF STREPTOCOCCAL PYROGENIC EXOTOXIN-A AND EXOTOXINC, Medical microbiology and immunology, 184(2), 1995, pp. 87-96
Authors:
EFFERTH T
FABRY U
GLATTE P
OSIEKA R
Citation: T. Efferth et al., EXPRESSION OF APOPTOSIS-RELATED ONCOPROTEINS AND MODULATION OF APOPTOSIS BY CAFFEINE IN HUMAN LEUKEMIC-CELLS, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 648-656
Authors:
VOLM M
EFFERTH T
Citation: M. Volm et T. Efferth, OVERCOMING DRUG-RESISTANCE OF TUMORS, Deutsche Medizinische Wochenschrift, 119(13), 1994, pp. 475-479
Authors:
SCHNEIDER J
EFFERTH T
RODRIGUEZESCUDERO FJ
VOLM M
Citation: J. Schneider et al., INTRINSIC OVEREXPRESSION OF 2 DIFFERENT MECHANISMS OF RESISTANCE TO CHEMOTHERAPY (P-GLYCOPROTEIN AND GST-PI) IN HUMAN ENDOMETRIAL CARCINOMA, Chemotherapy, 40(4), 1994, pp. 265-271
Authors:
EFFERTH T
OSIEKA R
Citation: T. Efferth et R. Osieka, CLINICAL RELEVANCE OF THE MDR-1 GENE AND ITS GENE-PRODUCT, P-GLYCOPROTEIN, FOR CANCER-CHEMOTHERAPY - A METAANALYSIS, Tumordiagnostik & Therapie, 14(6), 1993, pp. 238-243
Authors:
EFFERTH T
VOLM M
Citation: T. Efferth et M. Volm, REVERSAL OF DOXORUBICIN-RESISTANCE IN SARCOMA-180 TUMOR-CELLS BY INHIBITION OF DIFFERENT RESISTANCE MECHANISMS, Cancer letters, 70(3), 1993, pp. 197-202
Authors:
EFFERTH T
DUNN TA
BERLION M
LANGENBAHN H
POMMERENKE EW
VOLM M
Citation: T. Efferth et al., REVERSAL OF INHERENT MULTIDRUG-RESISTANCE IN PRIMARY HUMAN RENAL-CELLCARCINOMA CELL-CULTURES BY S-9788, Anticancer research, 13(4), 1993, pp. 905-908
Authors:
EFFERTH T
VOLM M
Citation: T. Efferth et M. Volm, MODULATION OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE BY MONOCLONAL-ANTIBODIES, IMMUNOTOXINS OR ANTISENSE OLIGODEOXYNUCLEOTIDES IN KIDNEY CARCINOMA AND NORMAL KIDNEY-CELLS, Oncology, 50(4), 1993, pp. 303-308
Authors:
VOLM M
KASTEL M
MATTERN J
EFFERTH T
Citation: M. Volm et al., EXPRESSION OF RESISTANCE FACTORS (P-GLYCOPROTEIN, GLUTATHIONE-S-TRANSFERASE-PI, AND TOPOISOMERASE-II) AND THEIR INTERRELATIONSHIP TO PROTOONCOGENE PRODUCTS IN RENAL-CELL CARCINOMAS, Cancer, 71(12), 1993, pp. 3981-3987
Authors:
EFFERTH T
VOLM M
Citation: T. Efferth et M. Volm, INCREASE OF ALKALINE-PHOSPHATASE IN MULTIDRUG-RESISTANT TUMOR-CELLS AND THEIR CROSS-RESISTANCE TO 6-THIOGUANINE, Arzneimittel-Forschung, 43-2(10), 1993, pp. 1118-1121
Risultati:
1-16
|